NAC (N-Acetyl Cysteine) vs Nattokinase

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

NAC (N-Acetyl Cysteine)Nattokinase
CategorySupplementsSupplements
Standard Dose600-1200mg daily2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg
TimingOn empty stomach for best absorption, 30 min before meals. Split doses if >600mg.On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.
Cycle DurationCycle 8 weeks on, 2 weeks off (to avoid potential downregulation of endogenous GSH production)ongoing
Evidence Levelstrong_humanmoderate_human

Mechanism

NAC is a precursor to L-cysteine, the rate-limiting substrate for glutathione (GSH) synthesis via glutamate-cysteine ligase. It directly replenishes intracellular GSH, the master endogenous antioxidant. NAC also modulates glutamatergic neurotransmission by stimulating the cystine-glutamate antiporter (system Xc-), influencing extrasynaptic glutamate levels. Additionally, it acts as a mucolytic by cleaving disulfide bonds in mucus glycoproteins.

Standard Dosing

600-1200mg daily

Timing

On empty stomach for best absorption, 30 min before meals. Split doses if >600mg.

Cycle Duration

Cycle 8 weeks on, 2 weeks off (to avoid potential downregulation of endogenous GSH production)

Side Effects

  • Nausea
  • GI upset
  • Sulfurous odor/taste
  • Rare: skin rash
  • Potential zinc/copper chelation at very high doses

Contraindications

  • Active gastric ulcers (may increase gastric acid)
  • Asthma (rare bronchospasm with inhaled form)
  • Concurrent chemotherapy (discuss with oncologist)

Best Stacking Partners

Vitamin CSeleniumAlpha Lipoic AcidGlycineMilk Thistle
B

Nattokinase

Supplements

Mechanism

Nattokinase is a fibrinolytic serine protease extracted from natto (fermented soybeans). It directly degrades fibrin (the structural protein of blood clots) through four mechanisms: direct fibrinolysis, enhancement of endogenous tPA (tissue plasminogen activator) production, conversion of prourokinase to urokinase, and degradation of PAI-1 (plasminogen activator inhibitor-1). It also reduces blood viscosity and may inhibit ACE (angiotensin-converting enzyme), providing mild antihypertensive effects.

Standard Dosing

2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg

Timing

On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.

Cycle Duration

ongoing

Side Effects

  • Easy bruising
  • Nosebleeds
  • GI upset
  • Rare: serious bleeding events

Contraindications

  • Active bleeding or bleeding disorders
  • Scheduled surgery (discontinue 2+ weeks prior)
  • Concurrent anticoagulant/antiplatelet therapy
  • Hemorrhagic stroke history
  • Soy allergy
  • Active bleeding
  • Bleeding disorders
  • Pre-surgery (stop 2 weeks prior)
  • Concurrent anticoagulation therapy without physician supervision

Best Stacking Partners

SerrapeptaseOmega-3Vitamin K2 (for balanced coagulation support)

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →